Ifosfamide‐induced acute kidney injury in a patient with leiomyosarcoma: A case report

Abstract Background Leiomyosarcoma (LMS) is an aggressive soft tissue sarcoma that is derived from smooth muscles. Ifosfamide is in use for advanced metastatic LMS. Case A‐44‐years old woman with a chief complaint of pain in the epigastric area, itching, coughing, nausea, and vomiting was referred t...

Fuld beskrivelse

Bibliografiske detaljer
Main Authors: Javad Boskabadi, Ehsan Yousefi‐Mazhin, Ebrahim Salehifar
Format: Article
Sprog:English
Udgivet: Wiley 2022-10-01
Serier:Cancer Reports
Fag:
Online adgang:https://doi.org/10.1002/cnr2.1666
_version_ 1828344154755694592
author Javad Boskabadi
Ehsan Yousefi‐Mazhin
Ebrahim Salehifar
author_facet Javad Boskabadi
Ehsan Yousefi‐Mazhin
Ebrahim Salehifar
author_sort Javad Boskabadi
collection DOAJ
description Abstract Background Leiomyosarcoma (LMS) is an aggressive soft tissue sarcoma that is derived from smooth muscles. Ifosfamide is in use for advanced metastatic LMS. Case A‐44‐years old woman with a chief complaint of pain in the epigastric area, itching, coughing, nausea, and vomiting was referred to the emergency department. Her medical history was LMS. She had taken Ifosfamide and mesna in her last chemotherapy. Seventy percent of her liver and her left kidney were removed 4 years ago to prevent the progress of the disease. Because of the increase in the level of creatinine and urea in the initial laboratory report, a Shaldon catheter was inserted for the patient, and she was under emergency dialysis for 3 h. In addition, during the six‐day hospitalization period, dialysis was done two times. Finally, the patient was discharged with improved clinical tests accompanied by a twice‐weekly dialysis order. Conclusion Ifosfamide is metabolized into chloroacetaldehyde, which can cause acute kidney injury. Recovery from acute kidney injury may not always be perfect and can lead to some degree of chronic kidney disease. Opposite to hemorrhagic cystitis, mesna is not effective in preventing ifosfamide's nephrotoxicity and N‐acetylcysteine may be effective in the prevention of this nephrotoxicity.
first_indexed 2024-04-13T23:52:30Z
format Article
id doaj.art-248814c67aa04763ab0f2bc5880f2b51
institution Directory Open Access Journal
issn 2573-8348
language English
last_indexed 2024-04-13T23:52:30Z
publishDate 2022-10-01
publisher Wiley
record_format Article
series Cancer Reports
spelling doaj.art-248814c67aa04763ab0f2bc5880f2b512022-12-22T02:24:01ZengWileyCancer Reports2573-83482022-10-01510n/an/a10.1002/cnr2.1666Ifosfamide‐induced acute kidney injury in a patient with leiomyosarcoma: A case reportJavad Boskabadi0Ehsan Yousefi‐Mazhin1Ebrahim Salehifar2Student Research Committee, Pharmaceutical Sciences Research Center, Hemoglobinopathy Institute, Department of Clinical Pharmacy Mazandaran University of Medical Sciences Sari IranStudent Research Committee, Pharmaceutical Sciences Research Center, Hemoglobinopathy Institute, Department of Clinical Pharmacy Mazandaran University of Medical Sciences Sari IranPharmaceutical Sciences Research Center, Hemoglobinopathy Institute, Department of Clinical Pharmacy Mazandaran University of Medical Sciences Sari IranAbstract Background Leiomyosarcoma (LMS) is an aggressive soft tissue sarcoma that is derived from smooth muscles. Ifosfamide is in use for advanced metastatic LMS. Case A‐44‐years old woman with a chief complaint of pain in the epigastric area, itching, coughing, nausea, and vomiting was referred to the emergency department. Her medical history was LMS. She had taken Ifosfamide and mesna in her last chemotherapy. Seventy percent of her liver and her left kidney were removed 4 years ago to prevent the progress of the disease. Because of the increase in the level of creatinine and urea in the initial laboratory report, a Shaldon catheter was inserted for the patient, and she was under emergency dialysis for 3 h. In addition, during the six‐day hospitalization period, dialysis was done two times. Finally, the patient was discharged with improved clinical tests accompanied by a twice‐weekly dialysis order. Conclusion Ifosfamide is metabolized into chloroacetaldehyde, which can cause acute kidney injury. Recovery from acute kidney injury may not always be perfect and can lead to some degree of chronic kidney disease. Opposite to hemorrhagic cystitis, mesna is not effective in preventing ifosfamide's nephrotoxicity and N‐acetylcysteine may be effective in the prevention of this nephrotoxicity.https://doi.org/10.1002/cnr2.1666acute kidney injuryifosfamideleiomyosarcomamesnaN‐acetylcysteine
spellingShingle Javad Boskabadi
Ehsan Yousefi‐Mazhin
Ebrahim Salehifar
Ifosfamide‐induced acute kidney injury in a patient with leiomyosarcoma: A case report
Cancer Reports
acute kidney injury
ifosfamide
leiomyosarcoma
mesna
N‐acetylcysteine
title Ifosfamide‐induced acute kidney injury in a patient with leiomyosarcoma: A case report
title_full Ifosfamide‐induced acute kidney injury in a patient with leiomyosarcoma: A case report
title_fullStr Ifosfamide‐induced acute kidney injury in a patient with leiomyosarcoma: A case report
title_full_unstemmed Ifosfamide‐induced acute kidney injury in a patient with leiomyosarcoma: A case report
title_short Ifosfamide‐induced acute kidney injury in a patient with leiomyosarcoma: A case report
title_sort ifosfamide induced acute kidney injury in a patient with leiomyosarcoma a case report
topic acute kidney injury
ifosfamide
leiomyosarcoma
mesna
N‐acetylcysteine
url https://doi.org/10.1002/cnr2.1666
work_keys_str_mv AT javadboskabadi ifosfamideinducedacutekidneyinjuryinapatientwithleiomyosarcomaacasereport
AT ehsanyousefimazhin ifosfamideinducedacutekidneyinjuryinapatientwithleiomyosarcomaacasereport
AT ebrahimsalehifar ifosfamideinducedacutekidneyinjuryinapatientwithleiomyosarcomaacasereport